Biomarkers of aging

Aging Biomarker Consortium, H Bao, J Cao… - Science China Life …, 2023 - Springer
Aging biomarkers are a combination of biological parameters to (i) assess age-related
changes,(ii) track the physiological aging process, and (iii) predict the transition into a …

Cellular senescence in hepatocellular carcinoma: the passenger or the driver?

X Cai, A Guillot, H Liu - Cells, 2022 - mdpi.com
With the high morbidity and mortality, hepatocellular carcinoma (HCC) represents a major
yet growing burden for our global community. The relapse-prone nature and drug resistance …

[HTML][HTML] Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2

N Cheng, KH Kim, LF Lau - JCI insight, 2022 - ncbi.nlm.nih.gov
Senescent cells have long been associated with deleterious effects in aging-related
pathologies, although recent studies have uncovered their beneficial roles in certain …

Acquisition of epithelial plasticity in human chronic liver disease

C Gribben, V Galanakis, A Calderwood, EC Williams… - Nature, 2024 - nature.com
For many adult human organs, tissue regeneration during chronic disease remains a
controversial subject. Regenerative processes are easily observed in animal models, and …

Hedgehog signaling: implications in liver pathophysiology

RK Dutta, JH Jun, K Du, AM Diehl - Seminars in Liver Disease, 2023 - thieme-connect.com
The purpose of this review is to summarize current knowledge about the role of the
Hedgehog signaling pathway in liver homeostasis and disease. Hedgehog is a …

Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression

R Maeso-Díaz, K Du, C Pan, CD Guy, SH Oh… - Hepatology, 2023 - journals.lww.com
Targeting senescent hepatocytes using the thrombomodulin-PAR... : Hepatology Targeting
senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates …

The potential role of cellular senescence in non-alcoholic fatty liver disease

C Engelmann, F Tacke - International journal of molecular sciences, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) represents an increasing global health burden.
Cellular senescence develops in response to cellular injury, leading not only to cell cycle …

New trends in aging drug discovery

B Benhamú, M Martín-Fontecha, H Vázquez-Villa… - Biomedicines, 2022 - mdpi.com
Aging is considered the main risk factor for many chronic diseases that frequently appear at
advanced ages. However, the inevitability of this process is being questioned by recent …

Stress-induced premature senescence related to oxidative stress in the developmental programming of nonalcoholic fatty liver disease in a rat model of intrauterine …

B Keshavjee, V Lambelet, H Coppola, D Viertl, JO Prior… - Antioxidants, 2022 - mdpi.com
Metabolic syndrome (MetS) refers to cardiometabolic risk factors, such as visceral obesity,
dyslipidemia, hyperglycemia/insulin resistance, arterial hypertension and non-alcoholic fatty …

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

M Raffaele, K Kovacovicova, T Biagini, O Lo Re… - GeroScience, 2022 - Springer
Accumulation of senescent cells may drive age-associated alterations and pathologies.
Senolytics are promising therapeutics that can preferentially eliminate senescent cells. Here …